These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 31159216)

  • 21. Evidence of acceptability of oral paediatric medicines: a review.
    Mistry P; Batchelor H;
    J Pharm Pharmacol; 2017 Apr; 69(4):361-376. PubMed ID: 27524471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Challenges in pediatric drug use: A pharmacist point of view.
    Balan S; Hassali MA; Mak VSL
    Res Social Adm Pharm; 2017; 13(3):653-655. PubMed ID: 27493130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formulation and Stability of Solutions.
    Akers MJ
    Int J Pharm Compd; 2016; 20(1):41-5. PubMed ID: 27127830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Practical and operational considerations related to paediatric oral drug formulation: An industry survey.
    Van der Veken M; Brouwers J; Budts V; Lauwerys L; Pathak SM; Batchelor H; Augustijns P
    Int J Pharm; 2022 Apr; 618():121670. PubMed ID: 35304242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safe, swallowable and palatable paediatric mini-tablet formulations for a WHO model list of essential medicines for children compound - A promising starting point for future PUMA applications.
    Freerks L; Sommerfeldt J; Löper PC; Klein S
    Eur J Pharm Biopharm; 2020 Nov; 156():11-19. PubMed ID: 32871197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting our snacking culture to improve patient compliance.
    Shahiwala A
    Ther Deliv; 2012 May; 3(5):579-81. PubMed ID: 22834402
    [No Abstract]   [Full Text] [Related]  

  • 27. Basics of Sterile Compounding: Biopharmaceutics of Injectable Dosage Forms.
    Akers MJ
    Int J Pharm Compd; 2017; 21(1):47-56. PubMed ID: 28346198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acceptability of an orodispersible film compared to syrup in neonates and infants: A randomized controlled trial.
    Klingmann V; Pohly CE; Meissner T; Mayatepek E; Möltner A; Flunkert K; Breitkreutz J; Bosse HM
    Eur J Pharm Biopharm; 2020 Jun; 151():239-245. PubMed ID: 32348882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Age-Appropriate Formulations Including Pharmaceutical Excipients in Neonatal Medicines.
    Kogermann K; Lass J; Nellis G; Metsvaht T; Lutsar I
    Curr Pharm Des; 2017; 23(38):5779-5789. PubMed ID: 28950820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recommended strategies for the oral administration of paediatric medicines with food and drinks in the context of their biopharmaceutical properties: a review.
    Martir J; Flanagan T; Mann J; Fotaki N
    J Pharm Pharmacol; 2017 Apr; 69(4):384-397. PubMed ID: 27704550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pediatric formulation issues identified in Paediatric Investigation Plans.
    Quijano Ruiz B; Desfontaine E; Arenas-López S; Wang S
    Expert Rev Clin Pharmacol; 2014 Jan; 7(1):25-30. PubMed ID: 24308789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neonatal drug therapy: The first frontier of therapeutics for children.
    Allegaert K; van den Anker J
    Clin Pharmacol Ther; 2015 Sep; 98(3):288-97. PubMed ID: 26095519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paediatric biopharmaceutics classification system: current status and future decisions.
    Batchelor H;
    Int J Pharm; 2014 Aug; 469(2):251-3. PubMed ID: 24602991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paediatric Formulation: Design and Development.
    Lopalco A; Denora N
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32992469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safe and effective pharmacotherapy in infants and preschool children: importance of formulation aspects.
    van Riet-Nales DA; Schobben AF; Vromans H; Egberts TC; Rademaker CM
    Arch Dis Child; 2016 Jul; 101(7):662-9. PubMed ID: 26979250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral biopharmaceutics tools - time for a new initiative - an introduction to the IMI project OrBiTo.
    Lennernäs H; Aarons L; Augustijns P; Beato S; Bolger M; Box K; Brewster M; Butler J; Dressman J; Holm R; Julia Frank K; Kendall R; Langguth P; Sydor J; Lindahl A; McAllister M; Muenster U; Müllertz A; Ojala K; Pepin X; Reppas C; Rostami-Hodjegan A; Verwei M; Weitschies W; Wilson C; Karlsson C; Abrahamsson B
    Eur J Pharm Sci; 2014 Jun; 57():292-9. PubMed ID: 24189462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paediatric Drug Development and Formulation Design-a European Perspective.
    Van Riet-Nales DA; Kozarewicz P; Aylward B; de Vries R; Egberts TC; Rademaker CM; Schobben AF
    AAPS PharmSciTech; 2017 Feb; 18(2):241-249. PubMed ID: 27270905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipid excipients and delivery systems for pharmaceutical development: a regulatory perspective.
    Chen ML
    Adv Drug Deliv Rev; 2008 Mar; 60(6):768-77. PubMed ID: 18077051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Basics of Compounding: Compounding Films.
    Allen LV
    Int J Pharm Compd; 2016; 20(4):298-305. PubMed ID: 28333675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dosage form design and development.
    Allen LV
    Clin Ther; 2008 Nov; 30(11):2102-11. PubMed ID: 19108798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.